201 related articles for article (PubMed ID: 21362152)
1. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
Hasenau AL; Nielsen G; Morisseau C; Hammock BD; Wulff H; Köhler R
Acta Physiol (Oxf); 2011 Sep; 203(1):117-26. PubMed ID: 21362152
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
[TBL] [Abstract][Full Text] [Related]
3. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
4. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.
Radtke J; Schmidt K; Wulff H; Köhler R; de Wit C
Br J Pharmacol; 2013 Sep; 170(2):293-303. PubMed ID: 23734697
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of
Kloza M; Baranowska-Kuczko M; Toczek M; Kusaczuk M; Sadowska O; Kasacka I; Kozłowska H
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450834
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.
Grgic I; Kaistha BP; Hoyer J; Köhler R
Br J Pharmacol; 2009 Jun; 157(4):509-26. PubMed ID: 19302590
[TBL] [Abstract][Full Text] [Related]
7. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
Wölfle SE; Schmidt VJ; Hoyer J; Köhler R; de Wit C
Cardiovasc Res; 2009 Jun; 82(3):476-83. PubMed ID: 19218287
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.
Mishra RC; Wulff H; Hill MA; Braun AP
J Cardiovasc Pharmacol; 2015 Jul; 66(1):118-27. PubMed ID: 25815673
[TBL] [Abstract][Full Text] [Related]
9. SKA-31, an activator of endothelial Ca
Khaddaj-Mallat R; Mathew John C; Braun AP
Eur J Pharmacol; 2018 Jul; 831():60-67. PubMed ID: 29753043
[TBL] [Abstract][Full Text] [Related]
10. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
[TBL] [Abstract][Full Text] [Related]
11. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
Oliván-Viguera A; Valero MS; Coleman N; Brown BM; Laría C; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Wulff H; Badorrey R; Köhler R
Mol Pharmacol; 2015 Feb; 87(2):338-48. PubMed ID: 25468883
[TBL] [Abstract][Full Text] [Related]
12. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel.
Si H; Heyken WT; Wölfle SE; Tysiac M; Schubert R; Grgic I; Vilianovich L; Giebing G; Maier T; Gross V; Bader M; de Wit C; Hoyer J; Köhler R
Circ Res; 2006 Sep; 99(5):537-44. PubMed ID: 16873714
[TBL] [Abstract][Full Text] [Related]
13. KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca
Mishra RC; Kyle BD; Kendrick DJ; Svystonyuk D; Kieser TM; Fedak PWM; Wulff H; Braun AP
Metabolism; 2021 Jan; 114():154390. PubMed ID: 33039407
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat.
Khaddaj Mallat R; Mathew John C; Mishra RC; Kendrick DJ; Braun AP
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315169
[TBL] [Abstract][Full Text] [Related]
15. Endothelial K
Li JJ; Zhao XY; Wang Y; Xu R; Di XH; Zhang Y; Yang H; Han MZ; Bai RY; Xie L; Pang ZD; Zhang X; Zhang J; Du XJ; Deng XL; Zhang Y; Xie W
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):726-738. PubMed ID: 36951065
[TBL] [Abstract][Full Text] [Related]
16. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
17. Evidence for functional and dynamic microcompartmentation of Cav-1/TRPV4/K(Ca) in caveolae of endothelial cells.
Goedicke-Fritz S; Kaistha A; Kacik M; Markert S; Hofmeister A; Busch C; Bänfer S; Jacob R; Grgic I; Hoyer J
Eur J Cell Biol; 2015; 94(7-9):391-400. PubMed ID: 26116074
[TBL] [Abstract][Full Text] [Related]
18. Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular Bed.
Oliván-Viguera A; Valero MS; Pinilla E; Amor S; García-Villalón ÁL; Coleman N; Laría C; Calvín-Tienza V; García-Otín ÁL; Fernández-Fernández JM; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Badorrey R; Simonsen U; Rivera L; Wulff H; Köhler R
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):184-92. PubMed ID: 26821335
[TBL] [Abstract][Full Text] [Related]
19. Impaired EDHF-mediated vasodilation and function of endothelial Ca-activated K channels in uremic rats.
Köhler R; Eichler I; Schönfelder H; Grgic I; Heinau P; Si H; Hoyer J
Kidney Int; 2005 Jun; 67(6):2280-7. PubMed ID: 15882269
[TBL] [Abstract][Full Text] [Related]
20. SKA-31, an activator of Ca
John CM; Khaddaj Mallat R; Mishra RC; George G; Singh V; Turnbull JD; Umeshappa CS; Kendrick DJ; Kim T; Fauzi FM; Visser F; Fedak PWM; Wulff H; Braun AP
Pharmacol Res; 2020 Jan; 151():104539. PubMed ID: 31707036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
